170 related articles for article (PubMed ID: 15265190)
1. Bone mineral metabolism changes in epileptic children receiving valproic acid.
Oner N; Kaya M; Karasalihoğlu S; Karaca H; Celtik C; Tütüncüler F
J Paediatr Child Health; 2004 Aug; 40(8):470-3. PubMed ID: 15265190
[TBL] [Abstract][Full Text] [Related]
2. [Effect of carbamazepine and valproate on bone metabolism in children with epilepsy].
Song XQ; Wang ZP; Bao KR; Zhang JM; Wu J; Yan CH; Shen XM
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):728-32. PubMed ID: 16255847
[TBL] [Abstract][Full Text] [Related]
3. The effect of valproate on bone mineral density in adult epileptic patients.
Boluk A; Guzelipek M; Savli H; Temel I; Ozişik HI; Kaygusuz A
Pharmacol Res; 2004 Jul; 50(1):93-7. PubMed ID: 15082034
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy.
Tsukahara H; Kimura K; Todoroki Y; Ohshima Y; Hiraoka M; Shigematsu Y; Tsukahara Y; Miura M; Mayumi M
Pediatr Int; 2002 Jun; 44(3):247-53. PubMed ID: 11982890
[TBL] [Abstract][Full Text] [Related]
5. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy.
Guo CY; Ronen GM; Atkinson SA
Epilepsia; 2001 Sep; 42(9):1141-7. PubMed ID: 11580761
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of bone mineral density in children receiving antiepileptic drugs.
Akin R; Okutan V; Sarici U; Altunbas A; Gökçay E
Pediatr Neurol; 1998 Aug; 19(2):129-31. PubMed ID: 9744632
[TBL] [Abstract][Full Text] [Related]
7. The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine.
Serin HM; Koç ZP; Temelli B; Esen İ
Epilepsy Behav; 2015 Oct; 51():221-4. PubMed ID: 26298867
[TBL] [Abstract][Full Text] [Related]
8. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
Buyukkaplan US; Akkaya A; Yildiz M; Bircan A; Aksoy Dogan A; Ozturk O
J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
[TBL] [Abstract][Full Text] [Related]
9. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years.
Kafali G; Erselcan T; Tanzer F
Clin Pediatr (Phila); 1999 Feb; 38(2):93-8. PubMed ID: 10047942
[TBL] [Abstract][Full Text] [Related]
10. Bone health and vitamin D status in young epilepsy patients on valproate monotherapy.
Albaghdadi O; Alhalabi MS; Alourfi Z; Youssef LA
Clin Neurol Neurosurg; 2016 Jul; 146():52-6. PubMed ID: 27150607
[TBL] [Abstract][Full Text] [Related]
11. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy.
Pack AM; Morrell MJ; Randall A; McMahon DJ; Shane E
Neurology; 2008 Apr; 70(18):1586-93. PubMed ID: 18443309
[TBL] [Abstract][Full Text] [Related]
12. Effects of valproic acid on bone mineral density and bone metabolism: A meta-analysis.
Fan D; Miao J; Fan X; Wang Q; Sun M
Seizure; 2019 Dec; 73():56-63. PubMed ID: 31756600
[TBL] [Abstract][Full Text] [Related]
13. The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy.
Heo K; Rhee Y; Lee HW; Lee SA; Shin DJ; Kim WJ; Song HK; Song K; Lee BI
Epilepsia; 2011 Oct; 52(10):1884-9. PubMed ID: 21692779
[TBL] [Abstract][Full Text] [Related]
14. The effects of antiepileptic drugs on the relationships between leptin levels and bone turnover in prepubertal children with epilepsy.
Aksoy A; Sönmez FM; Deger O; Hosver I; Karagüzel G
J Pediatr Endocrinol Metab; 2011; 24(9-10):703-8. PubMed ID: 22145460
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
Välimäki MJ; Tiihonen M; Laitinen K; Tähtelä R; Kärkkäinen M; Lamberg-Allardt C; Mäkelä P; Tunninen R
J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
[TBL] [Abstract][Full Text] [Related]
16. Effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy.
Triantafyllou N; Lambrinoudaki I; Armeni E; Evangelopoulos EM; Boufidou F; Antoniou A; Tsivgoulis G
J Neurol Sci; 2010 Mar; 290(1-2):131-4. PubMed ID: 20056251
[TBL] [Abstract][Full Text] [Related]
17. Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy.
Koo DL; Hwang KJ; Han SW; Kim JY; Joo EY; Shin WC; Lee HW; Seo DW; Hong SB
Epilepsy Res; 2014 Mar; 108(3):442-7. PubMed ID: 24507862
[TBL] [Abstract][Full Text] [Related]
18. Effect of vitamin D and calcium on bone mineral density in children with CP and epilepsy in full-time care.
Jekovec-Vrhovsek M; Kocijancic A; Prezelj J
Dev Med Child Neurol; 2000 Jun; 42(6):403-5. PubMed ID: 10875526
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid.
Erbayat Altay E; Serdaroğlu A; Tümer L; Gücüyener K; Hasanoğlu A
J Pediatr Endocrinol Metab; 2000; 13(7):933-9. PubMed ID: 10968482
[TBL] [Abstract][Full Text] [Related]
20. Adverse effects of antiepileptic drugs on bone mineral density.
Babayigit A; Dirik E; Bober E; Cakmakci H
Pediatr Neurol; 2006 Sep; 35(3):177-81. PubMed ID: 16939856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
